Abstract-Renal resistive index (RRI) measured by Doppler ultrasonography is associated with cardiovascular events and mortality in hypertensive, diabetic, and elderly patients. We studied the factors associated with high RRI (≥0.70) and its associations with mortality in chronic kidney disease patients without renal artery stenosis. We included 1962 patients with an estimated glomerular filtration rate of 15 to 59 mL/min per 1.73 m 2 who also had RRI measured (January 1, 2005, to October 2011) from an existing chronic kidney disease registry. Participants with renal artery stenosis (60%-99% or renal artery occlusion) were excluded. Multivariable logistic regression model was used to study factors associated with high RRI (≥0.70), and its association with mortality was studied using Kaplan-Meier plots and Cox proportional hazards model. Hypertension was prevalent in >90% of the patients. In the multivariable logistic regression, older age, female sex, diabetes mellitus, coronary artery disease, peripheral vascular disease, higher systolic blood pressure, and the use of β blockers were associated with higher odds of having RRI≥0.70. During a median follow-up of 2.2 years, 428 patients died. After adjusting for covariates, RRI≥0.70 was associated with increased mortality (adjusted hazard ratio, 1.29; 95% confidence interval, 1.02-1.65; P<0.05). This association was more pronounced among younger patients and those with stage 3 chronic kidney disease. Noncardiovascular/non-malignancy-related deaths were higher in those with RRI≥0.70. RRI≥0.70 is associated with higher mortality in hypertensive chronic kidney disease patients without clinically significant renal artery stenosis after accounting for other significant risk factors. Its evaluation may allow early identification of those who are at risk thereby potentially preventing or delaying adverse outcomes. 
C hronic kidney disease (CKD) is a public health problem and is associated with higher risk of cardiovascular disease and mortality. [1] [2] [3] While kidney function measures, such as estimated glomerular filtration rate (eGFR) and albuminuria serve as markers to assess cardiovascular and mortality risk, other novel measures to predict these outcomes in kidney disease are warranted. 4 Clinically, data from renal Doppler ultrasonography are usually used for assessing the patency of renal arteries during the work-up of secondary hypertension or decline in kidney function. Renal resistive index (RRI), calculated as (peak systolic velocity−enddiastolic velocity)/peak systolic velocity, is a noninvasive measure obtained from a renal Doppler study to investigate renal hemodynamics. In addition, RRI provides prognostic information relating to systemic vasculature, and an elevated RRI is associated with adverse outcomes in hypertensive, diabetic, and elderly patients. [5] [6] [7] [8] Few studies have examined the use of the RRI parameter in those with kidney disease. Previous reports suggest that RRI might serve as a surrogate measure for assessing renal arteriolosclerosis and interstitial damage. 9 Furthermore, RRI is reported to predict the outcome of therapy in those with renal artery stenosis and transplant dysfunction. [10] [11] [12] A recent study reported that a high RRI is associated with kidney disease progression in those without renal artery stenosis. 5 However, whether it could serve as a prognostic marker to predict mortality risk in CKD is less studied. Hence, we hypothesized that an elevated RRI will be associated with higher mortality in CKD patients without renal artery stenosis. To test this hypothesis, we examined the associations between RRI and all-cause mortality among patients with CKD who underwent renal Doppler ultrasound in our healthcare system. In addition, we studied whether these associations are modified by age, sex, and stage of kidney disease. We also report the cause-specific death details for patients who resided in the State of Ohio for whom we had the cause of death details.
Methods
This analysis was conducted using a pre-existing Electronic Health Record (EHR)-based CKD registry at our institution. The development and validation of our EHR-based CKD registry at Cleveland Clinic have been described in detail elsewhere.
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Study Population
Patients who met the following criteria from January 1, 2005, to October 31, 2011, were included: (1) had at least one face-to-face outpatient encounter with a Cleveland Clinic healthcare provider, (2) had 2 eGFR 15 to 59.9 mL/min per 1.73 m 2 that were at least 90 days apart (using the CKD Epidemiology Collaboration equation), 14 (3) had RRI measured using Renal Doppler ultrasonography within 1 year, before second eGFR<60 mL/min per 1.73 m 2 , or during study follow-up. Patients with renal artery stenosis (60%-99% stenosis or occlusion), solitary kidney, end-stage renal disease needing dialysis, and renal transplant before CKD diagnosis were excluded.
Definitions and Outcome Measures
Variables
Demographic details were extracted from the EHR. Diabetes mellitus, hypertension, coronary artery disease, and other comorbidities were defined using prespecified criteria and validated. 13 Relevant outpatient laboratory values were obtained from the EHR. Medication details were obtained from the EHR as history of any previous use at inception, except for the use of angiotensin-converting enzyme/ angiotensin receptor blocker and aldosterone antagonists (which are current use at the time of renal Doppler study) and were validated by one of the investigators (C.T.).
Renal Function
We applied the CKD Epidemiology Collaboration equation to patients who had 2 outpatient serum creatinine levels between January 1, 2005, and October 31, 2011, in our health system to calculate eGFR. All creatinine measurements were performed by the modified kinetic Jaffe reaction, using a Hitachi D 
Doppler Ultrasonography and RRI
The renal Doppler studies were performed within the accredited noninvasive vascular laboratory or the Radiology Department of Cleveland Clinic by certified ultrasound personnel using a low-frequency ultrasound transducer and a standardized diagnostic scanning protocol for image acquisition. Intraparenchymal renal vessels were assessed by color and spectral Doppler analysis. Using pulsed wave Doppler, blood flow velocities were measured from segmental arteries located in the upper, middle, and lower third of the kidney for RRI analysis. The peak systolic velocity (in centimeters per second) and the end-diastolic velocity (in centimeters per second) of each vessel was measured at the time of the study to calculate the RRI using the formula: RRI=(peak systolic velocity−end-diastolic velocity)/peak systolic velocity. The 3 values were averaged to obtain the mean RRI for each side of the kidney. The average value between the right and the left kidney was the RRI used for analysis. Ultrasound parameters used in our laboratory for diagnosis of renal artery stenosis of 60% to 99% have been previously described and validated. 15 
Mortality
The primary outcome of interest, all-cause mortality, was ascertained from our EHR and linkage of our CKD registry with the Social Security Death Index. We censored patients on November 2011. For cause-specific death analysis, we linked data for the State of Ohio residents with the Ohio death index mortality data. The underlying cause of death was coded according to the International Classification of Diseases, Tenth Revision. We grouped the underlying causes of death as per the National Center for Health Statistics for each coding system, except for some changes as outlined below. 16 We classified deaths into the following 3 major categories: (1) cardiovascular deaths, (2) malignancy, and (3) noncardiovascular/ non-malignancy-related deaths. We defined cardiovascular deaths as deaths caused by diseases of the heart, essential hypertension, cerebrovascular disease, atherosclerosis, or other diseases of the circulatory system (International Classification of Diseases, Tenth Revision codes I00-I78).
Statistical Analysis
We compared baseline characteristics between patients with RRI<0.70 and those ≥0.70 using χ 2 and t tests for categorical and continuous variables, respectively. We used a logistic regression model to evaluate the factors associated with having an RRI≥0.70. Variables that were significantly different between patients with high and normal RRI were included in the logistic model. We also ran an additional logistic regression model to evaluate the factors associated with having an RRI≥0.70 by including proteinuria in the multivariable model. We used a Kaplan-Meier curve and the log-rank test to evaluate the relationship between RRI≥0.70 and mortality. We also used unadjusted and adjusted Cox proportional hazards models to evaluate this relationship while adjusting for age, sex, race, eGFR, diabetes mellitus, smoking, coronary artery disease, congestive heart failure, cerebrovascular disease, peripheral vascular disease, body mass index (BMI) group, systolic blood pressure, diastolic blood pressure, angiotensin-converting enzyme/angiotensin receptor blocker use, aldosterone antagonist use, and statin use. We tested 2-way interactions between RRI≥0.70 and age>65 years, sex, race, eGFR>30, BMI>30 kg/m 2 , and diabetes mellitus. Inception point for survival analysis was the date of the second eGFR<60 mL/min per 1.73 m 2 or date of the renal ultrasound; whichever was last. Seven percent of patients were missing smoking status, 2% were missing BMI, and 7% were missing blood pressure data. We used multiple imputations (SAS proc MI) with the Markov Chain Monte Carlo method and a single chain to impute 5 data sets. All logistic and Cox models were performed on each of the 5 imputed data sets, and parameter estimates were combined using SAS MIanalyze. 17 To evaluate the effect of using multiple imputations, we fit the logistic and Cox models on complete cases only. We also fit a similar adjusted Cox model while considering RRI as a continuous variable. We performed a sensitivity analysis among the subset of patients for whom we had proteinuria data. For patients who were residents of the State of Ohio, we used a Poisson model to estimate and compare the age/ sex-adjusted cause-specific mortality rates by high and low RRI. We also tabulated the leading causes of death by high and low RRI.
All analyses were conducted using Unix SAS version 9.2 (SAS Institute, Cary, NC), and graphs were created using R 3.0.1 (The R Foundation for Statistical Computing, Vienna, Austria). The CKD registry and this study were approved by the Cleveland Clinic Institutional Review Board.
Results
Baseline Patient Characteristics
Between January 1, 2005, and October 31, 2011, 3025 patients included in our CKD registry had Renal Doppler ultrasound with RRI data. We excluded 1063 patients because they did not meet the specified inclusion criteria ( Figure S1 in the online-only Data Supplement) and among those, 525 patients were excluded because of renal artery stenosis. The clinical characteristics of the 1962 patients at baseline based on RRI≥0.70 versus <0.70 are presented in Table 1 . Patients with RRI≥0.70 were older and had lower mean eGFR and diastolic blood pressure. Comorbid conditions such as diabetes mellitus, hyperlipidemia, coronary artery disease, and congestive heart failure were higher in those with RRI≥0.70.
Factors Associated With RRI≥0.70
In the multivariable logistic regression model, older age, female sex, higher systolic blood pressure, coronary artery disease, peripheral vascular disease, and use of β blockers were associated with higher odds of having RRI≥0.70, whereas a higher diastolic blood pressure was associated with lower odds of having RRI≥0.70 (Table 2 ). The sensitivity analysis using only complete cases showed similar results. In the model that included those who had proteinuria data, proteinuria was not associated with RRI≥0.70 (Table S1 ).
RRI and All-Cause Mortality
With a median follow-up of 2.2 years, there were 428 deaths. The Kaplan-Meier analysis (Figure 1 ) showed significant differences in all-cause mortality for patients with CKD with RRI≥0.70 and RRI<0.70. After adjusting for age, sex, race, eGFR, systolic blood pressure, diastolic blood pressure, diabetes mellitus, coronary artery disease, congestive heart (Table 3) .
Interactions
The interaction between RRI≥0.70 and age >65 versus <65 years was significant (P=0.01), suggesting that the association between RRI≥0.70 and mortality was stronger among younger patients, and less so among older ones (Figure 2 ). There was also an interaction between RRI≥0.70 and eGFR>30 (P=0.01), suggesting that the association between RRI≥0.70 and mortality was significant only among those with eGFR>30 mL/min per 1.73 m 2 but not among those with eGFR<30 mL/min per 1.73 m 2 . We did not find any significant interaction between RRI≥0.70 and sex, race, diabetes mellitus, or BMI>30 kg/m 2 .
Sensitivity Analysis Among Patients With Proteinuria Data
In this cohort, 1193 patients had proteinuria data, and of those, 230 died during follow-up. In this subset, each 0.05-U increase in RRI was associated with a 13% higher risk of death (95% confidence interval, 
Causes of Death
Overall, 1633 of 1692 (83%) patients were Ohio residents. Three hundred and forty-seven Ohio residents died during study follow-up, and 334 of 347 (96%) were found in the Ohio death index. We tabulated the age-and sex-adjusted rates of death per 1000 years of follow-up for the main causes of death for those with RRI≥0.70 and <0.70. As noted in Table 4 , noncardiovascular/non-malignancy-related deaths were higher in those with RRI≥0.70. Table S2 shows the main causes of death for high and low RRI.
Discussion
RRI data are readily available from renal Doppler studies performed for patients with and without kidney disease. In this clinical population, over two third of patients with CKD (most of them with hypertension) without renal artery stenosis had RRI≥0.70. Several factors such as older age, female sex, and multiple comorbid conditions were associated with higher RRI. This analysis also showed that RRI≥0.70 is significantly associated with increased all-cause mortality even after adjusting for various confounding variables. Furthermore, the association between RRI≥0.70 and death was more pronounced among those who were younger and in those with stage 3 but not with stage 4 CKD. Deaths caused by noncardiovascular/ non-malignancy diseases were higher in those with RRI≥0.70. Previous studies have examined the association of RRI with kidney function decline in those with pre-existing kidney disease. 9, 18 In other disease states, such as diabetes mellitus and hypertension, RRI has been associated with cardiovascular events and death. 5, [19] [20] [21] Studies examining the associations between RRI and death are limited, particularly in those with *ORs shown were pooled using MIanalyze from 5 data sets created using multiple imputation. CKD. In newly diagnosed CKD patients with renal artery stenosis, Radermacher et al 22 (n=162) found that RRI >0.80 was associated with an increased risk for renal function decline, progression to end-stage renal disease, and death. Doi et al 5 (n=426) demonstrated that a high RRI was independently associated with worse composite outcomes (mortality, cardiovascular events, and renal events) in hypertensive patients. Moreover, the association was stronger in those with an eGFR <60 mL/min per 1.73 m 2 and high RRI (versus eGFR >60 mL/min per 1.73 m 2 and low RRI). Their study did not directly compare those with high and low RRI in the CKD population, and our analysis provides prognostic significance of RRI in CKD by comparing these groups directly, along with providing cause-specific death details. It is also important to note that these associations were more pronounced in younger patients and those with earlier stages of CKD, which have not been reported previously. Even though the clinical significance of such associations is not completely understood, interventions targeting this pathobiology through various measures such as appropriate blood pressure control and use of angiotensin-converting enzyme inhibitor/ angiotensin receptor blocker in hypertensive kidney disease with high RRI can be further explored in prospective studies. Particularly, the observed associations are stronger in younger patients suggesting a possibility for earlier intervention.
Even though key questions such as what RRI represents and why a high value associates with worse outcomes have not been completely elucidated, several studies support the notion that vascular stiffness is the most likely factor. [23] [24] [25] RRI represents both renal arterial resistance and compliance. Bigé et al 9 demonstrated that a high RRI was associated with severe arteriosclerosis, which may explain its association with cardiovascular risk. Furthermore, in patients with essential hypertension, RRI correlated with early signs of target organ damage such as carotid intimal-medial thickness and left ventricular hypertrophy. 7 Also, in kidney transplant patients, RRI of the allograft correlated more with the age of the recipient rather than that of the donor, 26 suggesting that extrarenal factors such as arterial stiffness contribute to RRI. These cardiovascular indices have long been established to correlate with worse cardiovascular outcomes, including mortality. In the cause-specific death analysis, we noted slightly higher cardiovascular deaths among those with RRI≥0.70, but this was not statistically significant. On the contrary, we noted a higher proportion of noncardiovascular/non-malignancy-related deaths. Table S2 shows the actual causes of death within this category and could also be a topic of future studies.
Similar to others, we found a positive correlation between RRI and older age. As shown in histological studies of the kidney, aging correlates with increased interstitial fibrosis and small vessel changes in the kidney. 9, 27 Diastolic blood pressure also tends to decrease with age as vessels become less compliant. In this analysis, among those with RRI≥0.70, diastolic blood pressure was noted to be lower and associate with RRI, suggesting the age-related effect on vascular compliance. Diabetics, at higher risk for atherosclerotic disease, also had higher odds of having an RRI≥0.70. This corroborates the findings of Ohta et al, 25 and the observed associations could possibly be explained by intrarenal atherosclerosis and arteriosclerosis. We have adjusted for these parameters (age, diastolic blood pressure, and hyperlipidemia) in the models to examine the independent associations of RRI with death. We also found that women have CI indicates confidence interval; HR, hazard ratio; and RRI, renal resistive index. *Adjusted for age, sex, race, estimated glomerular filtration rate, diabetes mellitus, coronary artery disease, congestive heart failure, cerebrovascular disease, peripheral vascular disease, smoking, body mass index group, systolic blood pressure, diastolic blood pressure, angiotensin-converting enzyme/angiotensin receptor blocker, aldosterone antagonists, and statins. higher odds of having an elevated RRI in our cohort as shown in previous studies. 5 Even though the exact reasons behind these associations are unclear, hormonal influences may play a role.
The strengths of our study include its large sample size by including patients with stage 3 and 4 CKD belonging to various races thereby enhancing the generalizability of our results. However, as an observational study, it has some limitations. We included patients followed in our health system who underwent renal Doppler ultrasound for an indication (subjecting to selection bias) such as uncontrolled hypertension or worsening renal function, which places them at higher risk for death. We attempted to address this by adjusting for several confounding variables in the multivariable Cox regression analysis. Furthermore, the observational nature of this study limits causal inferences. It is a single-center study limiting its potential for external validity, but such associations in a large CKD cohort have not been reported previously. We had missing data for some variables, but performed multiple imputations and complete case analysis, methods that have been suggested to address the missingness in studies of kidney disease. The results remained consistent across these analyses. It is also important to point out that the comparison of high RRI among the published reports is difficult given the different cutoffs used by these studies. We chose the RRI value of 0.70 as the cutoff, but analysis by considering RRI as a continuous measure yielded similar results. We also lacked data about underlying atherosclerotic disease in the setting of <60% renal artery stenosis. Even though previous studies have shown associations between proteinuria and RRI, we did not find such associations, which could be because of the lack of proteinuria data for ≈40% of our study population (Table S1 ).
Perspectives
RRI≥0.70 is associated with higher mortality in hypertensive CKD patients without clinically significant renal artery stenosis after accounting for other significant risk factors. Deaths caused by noncardiovascular/nonmalignancy reasons account for the higher mortality burden in those with higher RRI. Its evaluation may allow for early identification of those who are at risk, thereby potentially preventing or delaying adverse outcomes in CKD. Our results highlight the need for further prospective studies to provide conclusive evidence to guide clinical practice. *Odds ratios shown were pooled using MIanalyze from 5 datasets created using multiple imputation 
